Table 1.
Clinico‐pathological characteristics of breast cancer metastatic to gynaecological organs
| GM (n = 54) | QFU (n = 445) | P value | |
|---|---|---|---|
| Histological type | n (%) | n (%) | |
| IC‐NST | 26 (48.1) | 256 (57.5) | <0.0001 |
| ILC | 23 (42.6) | 64 (14.4) | |
| Other | 5 (9.3) | 124 (27.9) | |
| Age of breast cancer diagnosis | Years (95% CI) | Years (95% CI) | |
| Median | 46.5 (43–54) | 60 (57–62) | <0.0001* |
| Median ILC cases | 44.8 (41.6–53.9) | 62.5 (57–66) | <0.0001* |
| Median IC‐NST cases | 46 (41.8–56.8) | 58 (55–63) | 0.0022* |
| Range | 30–79 | 27–88 | |
| Menopausal status | n (%) | n (%) | |
| Premenopausal | 31 (57.4) | 141 (32.9) | 0.0004 |
| Postmenopausal | 23 (42.6) | 287 (67.1) | |
| Tumour size | n (%) | n (%) | |
| <2 cm | 14 (43.8) | 177 (46.6) | 0.1922 |
| 2–5 cm | 12 (37.5) | 169 (44.5) | |
| >5 cm | 6 (18.8) | 34 (8.9) | |
| Unknown | 22 | ||
| Tumour grade | n (%) | n (%) | |
| Grade 1 | 2 (6.6) | 63 (14.2) | 0.3622 |
| Grade 2 | 14 (46.7) | 220 (49.5) | |
| Grade 3 | 14 (46.7) | 161 (36.3) | |
| Unknown | 24 | ||
| Lymph node status | n (%) | n (%) | |
| Positive | 30 (83.3) | 116 (46.2) | <0.0001 |
| Negative | 6 (16.7) | 135 (53.8) | |
| Unknown | 18 | ||
| Age of first metastasis diagnosis | Years (95% CI) | ||
| Median | 54.4 (49.8–59.3) | ||
| Range | 35–82 | ||
| Number of metastatic sites | n (%) | ||
| 1–3 | 22 (40.7) | ||
| 4–11 | 32 (59.3) | ||
| Median | 5 | ||
| Range | 1–11 |
*
t‐test; all other P values were derived using Chi‐square analysis. Significant P values are underlined.